Last updated on November 2018

Registry of Patients Treated With Systemic Mold-Active Triazoles

Brief description of study

The purpose of this study is to describe representative real-world patterns of care for the management of invasive fungal infections (IFIs), including invasive mold infection (IMI). Specifically, the study goals are to examine real world patient characteristics and treatment patterns, associated healthcare resource utilization, and outcomes associated with use of mold-active triazoles (MATs) to treat invasive fungal infections (IFIs).

Clinical Study Identifier: NCT03066011

Contact Investigators or Research Sites near you

Start Over

Astellas Pharma Global Development

Robert Wood Johnson University Hospital Somerset
Somerville, NJ United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.